KYRNF vs MSFT: Which Stock is Better?

Side-by-side comparison of KYORIN Pharmaceutical Co., Ltd. and Microsoft Corp in 2026

Comparison Updated:

KYRNF

KYORIN Pharmaceutical Co., Ltd.

$10.31

MSFT

Microsoft Corp

$430.11

Key Metrics Comparison

MetricKYRNFMSFTWinner
Market Cap$592.33MN/AKYRNF
P/E Ratio10.1126.32KYRNF
EPS (TTM)$1.02$15.97MSFT
Revenue Growth-0.0%0.2%MSFT
Gross Margin45.3%68.6%MSFT

Analyze KYRNF

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KYRNF or MSFT a better investment?

Comparing KYRNF and MSFT: KYORIN Pharmaceutical Co., Ltd. has a market cap of $592.33M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KYRNF and MSFT?

KYRNF (KYORIN Pharmaceutical Co., Ltd.) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KYRNF or MSFT?

Based on P/E ratios, KYRNF trades at a lower multiple (10.1x vs 26.3x).

Which is growing faster: KYRNF or MSFT?

MSFT has higher revenue growth at 0.2% vs -0.0% for KYRNF.

Which company is more profitable: KYRNF or MSFT?

Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 45.3% for KYRNF.

Which is the larger company: KYRNF or MSFT?

KYORIN Pharmaceutical Co., Ltd. (KYRNF) is larger with a market cap of $592.33M compared to N/A for MSFT.

Should I buy KYRNF or MSFT in 2026?

Both KYRNF and MSFT have investment merit. KYRNF trades at $10.31 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KYRNF and MSFT stock?

Key differences: Market Cap ($592.33M vs N/A), P/E Ratio (10.1x vs 26.3x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (45.3% vs 68.6%).

Popular Stock Comparisons